Taken together, our data demonstrate that elevated LCN2 levels during human pancreatic cancer are associated with neutrophil expansion, increased fat and skeletal muscle catabolism, and decreased survival. This evidence concerns the gene LCN2 and familial pancreatic carcinoma.